Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SUNITINIB MALATE for Sarcoma metastatic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where SUNITINIB MALATE was used for Sarcoma metastatic.

Most Reported Side Effects for SUNITINIB MALATE

Side Effect Reports % Deaths Hosp.
Death 4,385 20.3% 4,379 361
Diarrhoea 3,044 14.1% 302 950
Fatigue 2,865 13.3% 302 869
Nausea 2,032 9.4% 235 729
Neoplasm progression 1,920 8.9% 545 558
Disease progression 1,745 8.1% 508 532
Decreased appetite 1,676 7.8% 274 696
Asthenia 1,651 7.7% 347 772
Vomiting 1,331 6.2% 232 637
Dysgeusia 1,226 5.7% 98 397
Malaise 1,202 5.6% 170 526
Hypertension 1,126 5.2% 93 406
Weight decreased 1,120 5.2% 156 453
Stomatitis 985 4.6% 90 306
Pain in extremity 977 4.5% 88 267

Other Indications for SUNITINIB MALATE

Metastatic renal cell carcinoma (4,271) Renal cell carcinoma (2,926) Renal cancer (2,750) Gastrointestinal stromal tumour (1,696) Renal cancer metastatic (871) Neoplasm malignant (646) Product used for unknown indication (368) Renal cancer stage iv (357) Pancreatic neuroendocrine tumour (314) Clear cell renal cell carcinoma (244)

Other Drugs Used for Sarcoma metastatic

DOXORUBICIN (114) TRABECTEDIN (53) IFOSFAMIDE (49) DOCETAXEL (39) PAZOPANIB (39) GEMCITABINE (33) MESNA (23) GEMCITABINE\GEMCITABINE (21) OLARATUMAB (21) VINCRISTINE (20)

Related Pages

SUNITINIB MALATE Full Profile All Sarcoma metastatic Drugs SUNITINIB MALATE Demographics SUNITINIB MALATE Timeline